Rx only · Tablet · Oral
Levothyroxine And Liothyronine
Brands: Evexithroid · Renthyroid · Levothyroxine + Liothyronine
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)10572
US makers2 labelers
Packages31
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.796
Latest avg · Jul 22, 2026
-2%
Since Jan 21, 2026
2
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Genus Lifesciences | unknown | 23 | SUPPLYING |
| Trifluent Pharma LLC | unknown | 8 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.
Pill